The funding round was led by returning investors Verve Ventures and Zurich Kantonalbank. It also had the participation of the 212 NextT Fund.

Haelixa also benefited from catalytic funding through the Temasek Trust Amplifier programme.

The company’s proprietary DNA marker technology is designed to provide physical verification of product origin and authenticity.

The solution aims to improve traceability and support brand compliance, addressing growing regulatory scrutiny and industry concerns such as fraud, undeclared blending and counterfeiting.

It is currently used in sectors such as textiles, precious metals and gemstones, and is aligned with recognized standards such as GOTS and OEKO-TEX.

Gizem Yağız, managing partner of 212 NexT Fund, said: “The lack of transparency in supply chains today poses serious financial and reputational risks for brands. Haelixa’s DNA-based approach materially reduces this risk by scientifically verifying product origin and authenticity directly on the product itself. We are proud to join this founding round and support the Standard Team for Traceability.”

Haelixa plans to use the funds to support selective team growth, a broader product offering and greater collaboration with textile brands and supply chain partners.

Haelixa CEO Patrick Strumpf said: “This investment allows us to scale globally as traceability expectations continue to rise. It also allows us to expand into the fight against counterfeiting, adding a strong new layer of value for luxury brands.”

Spinning out of ETH Zurich, Haelixa has achieved large-scale commercial adoption, generating seven-figure revenues and securing multi-year deals with leading fashion and textile brands.

In November last year, the company partnered with New Focus Textiles, a fabric manufacturer, to provide forensic evidence of recycled cotton content in textile manufacturing.

In addition, digital traceability platform TextileGenesis integrated Haelixa’s DNA-based certificates into its Fiber-to-Retail module in October last year, allowing suppliers to directly upload forensic traceability documents.

“Haelixa to advance DNA-based traceability technology with $2.3M funding” was originally created and published by Just stylea trademark owned by GlobalData.

The information on this site has been included in good faith for general informational purposes only. It is not intended to be advice on which you should rely, and we make no representations, warranties or guarantees, either express or implied, as to its accuracy or completeness. You should obtain professional or specialist advice before taking or refraining from any action based on the content of our site.